isoflutek 1000 mg/g væske til inhalationsdamp
laboratorios karizoo, s.a. - isofluran - væske til inhalationsdamp - 1000 mg/g
troxxan 25 mg/ml injektionsvæske, opløsning
laboratorios syva, s.a.u. - tulathromycin - injektionsvæske, opløsning - 25 mg/ml
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
maycetam 400 mg/ml opløsning til anvendelse i drikkevand
laboratorios maymó, s.a. - paracetamol - opløsning til anvendelse i drikkevand - 400 mg/ml
veterelin 0,004 mg/ml injektionsvæske, opløsning
laboratorios calier sa - buserelinacetat - injektionsvæske, opløsning - 0,004 mg/ml
porcivac ery parvo injektionsvæske, emulsion
laboratorios syva s.a. - erysipelothrix rhusiopathiae serotype 2 (inaktiveret), parvovirus, porcint - injektionsvæske, emulsion
cristalmina 10 mg/ml kutanspray, opløsning
laboratorios salvat, sa - chlorhexidindigluconat-opløsning (20%) - kutanspray, opløsning - 10 mg/ml
veteglan 0,075 mg/ml injektionsvæske, opløsning
laboratorios calier sa - cloprostenolnatrium - injektionsvæske, opløsning - 0,075 mg/ml
nexpovio
stemline therapeutics b.v. - selinexor - multipelt myelom - antineoplastiske midler - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
chemoterol 12 mikrogram inhalationspulver i kapsler
laboratorios liconsa, s.a. - formoterolfumarat dihydrat - inhalationspulver i kapsler - 12 mikrogram